e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Stress responses and T-cell behaviour in the lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of human neutrophil proteases on
ex vivo
small airway function
N. J. Madge, D. F. Rogers, L. E. Donnelly (London, United Kingdom)
Source:
Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Session:
Stress responses and T-cell behaviour in the lung
Session type:
Thematic Poster Session
Number:
3885
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. J. Madge, D. F. Rogers, L. E. Donnelly (London, United Kingdom). Effect of human neutrophil proteases on
ex vivo
small airway function. Eur Respir J 2013; 42: Suppl. 57, 3885
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Effects of pendrin inhibitor (PDI_C01) in vitro, and in vivo models of lipopolysaccharide-induced airway inflammation.
Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure
Year: 2019
Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation
Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response
Year: 2005
LSC - 2017 - Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
Ex vivo elastase and hydrogen peroxide stimulation in lung slices: novel models to study lung repair
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016
Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis
Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models
Year: 2016
The GPx1-PTP1B-PP2A axis: A key determinant of airway inflammation and alveolar destruction
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013
The effect of
in vitro
culture methods on corticosteroid sensitivity in COPD alveolar macrophages
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis
ex vivo
Source: Eur Respir J, 50 (2) 1602367; 10.1183/13993003.02367-2016
Year: 2017
Pulmonary alveolar proteinosis: iPS derived macrophages as in-vitro disease model and potential source for novel gene and cell therapies
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
cPLA2alpha inhibitor ASB14780 suppresses airway MMP-9 production and improves respiratory function in cigarette-smoke induced model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Neutrophil elastase contributes to activated human neutrophil-induced rat small airway dysfunction
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015
IL-13-induced cytokine release and hyperresponsiveness in precision cut lung slices of different species – Characterization of a model potentially suitable for translational research of asthma cellular events
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013
Role of endogenous interleukin-17 in early neutrophil recruitment after endotoxin exposure in mouse airways
in vivo
Source: Eur Respir J 2003; 22: Suppl. 45, 566s
Year: 2003
Galectin-9 attenuates elastase-induced emphysema by reducing neutrophil chemotaxis in mice
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Role of peroxiredoxin 6 in lipopolysaccharide-induced mucin production in mice
Source: Annual Congress 2013 –Molecular biology: state-of-the-art 2013
Year: 2013
Lung inflammation: The role of alveolar macrophages
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Pharmacological characterization of the protective effect of benralizumab against airway hyperresponsiveness in a human ex vivo model of severe asthma
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019
Regulation of GROα production in human bronchial epithelial cells
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
The human cathelicidin LL37 and mitochondrial DAMPs induce airway inflammation in epithelial cells and mice
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept